课题基金 / 基金详情

The mechanisms of action of the "catastrophe kinesins": Kinesins that destabilize the ends of microtubules

The mechanisms of action of the "catastrophe kinesins": Kinesins that destabilize the ends of microtubules
“灾难驱动蛋白”的作用机制:破坏微管末端稳定的驱动蛋白
批准号:
5310878
负责人:
Professor Dr. Anthony A. Hyman
金额:
$0.0万
依托单位国家:
德国
项目类别:
Priority Programmes
财政年份:
2001
资助国家:
德国
项目状态:
已结题
起止时间:
2000-12-31 至 2004-12-31

项目摘要

项目成果

Professor Dr. Anthony A. Hyman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The present research proposal is concerned with the mechanisms of action of a sub-family of the kinesins, the so-called "catastrophe-kinesins" which destabilize the ends of microtubules. These kinesins are essential for controlling the length and distribution of microtubule populations, by binding to microtubule ends, but little is know of their mechanism of action. Our group and others have 1) Established assays which examine the structural changes of microtubule ends during the change between growing and shrinking. This work has lead to the concept of a structural cap stabilizing growing microtubules. 2) Shown that the length of a microtubule population is controlled by the opposing activity of XKCM1, a catastrophe kinesin, and XMAP215, a MAP which stabilizes microtubules. In unpublished work, we have further shown the two proteins can oppose each other in the regulation of the growth of pure tubulin. In this project we propose to a) Correlate the structure of the microtubule end with the activity of XKCM1, by cryoelectron microscopy. b) To investigate how the activity of XKCM1 is modulated by the activity of XMAP 215.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Post-translational control of gene expression noise by liquid-liquid phase separation
Cell polarity in C.elegans
国内基金
海外基金
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
  • 批准号:
    82371028
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵慧
  • 依托单位:
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
  • 批准号:
    82372743
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陈卓佳
  • 依托单位:
空气颗粒物通过调控白血病抑制因子参与影响IgA肾病进展的作用与机制研究
  • 批准号:
    82370711
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    谢静远
  • 依托单位:
原发性开角型青光眼中SIPA1L1促进小梁网细胞外基质蛋白累积升高眼压的作用机制
  • 批准号:
    82371054
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    郭涛
  • 依托单位: